免疫治疗、化疗被证实存在一定疗效。分子靶向研究是恶性黑色素瘤治疗的新趋势。
The immunotherapy and chemotherapeutics confirmed existence certain curative effect, Molecular staging and targeted therapy may will be the new tendency in future.
首先，研究人员不知道人类成血干细胞同样的分子是否刚好是治疗的靶向细胞。
First, the researchers don't know whether the same molecule on human blood-forming stem cells would be the right one to target with a therapy.
这方面的进展代表着在这个复杂疾病处理上的一个突破。肝癌具有多药耐药性，但研究证明这种分子靶向对其治疗是有效的。
This advancement represents a breakthrough in the management of this complex disease, and proves that molecular targeted therapies can be effective in this otherwise chemo-resistant tumor.
应用推荐